Production (Stage)
Sage Therapeutics, Inc.
SAGE
$6.46
-$0.06-0.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -40.89% | -33.03% | -35.03% | -35.49% | -36.52% |
| Total Receivables | 27.79% | -85.40% | -19.73% | -34.11% | -29.95% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -35.34% | -43.58% | -52.66% | -37.95% | -54.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -39.84% | -38.89% | -35.18% | -35.45% | -37.23% |
|
|
|||||
| Total Current Assets | -39.84% | -38.89% | -35.18% | -35.45% | -37.23% |
| Net Property, Plant & Equipment | 150.68% | 82.52% | 44.90% | -75.16% | -62.12% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -47.41% | -34.67% | -34.70% | -5.12% | 39.68% |
| Total Assets | -38.81% | -37.98% | -34.46% | -35.59% | -37.12% |
|
|
|||||
| Total Accounts Payable | -16.11% | 23.08% | -36.01% | -6.82% | -47.17% |
| Total Accrued Expenses | -27.69% | -25.38% | -41.48% | -27.04% | -23.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -45.19% | -74.48% | -98.81% | -81.73% | -56.98% |
| Total Finance Division Other Current Liabilities | 163.94% | 44.56% | -99.37% | -- | -- |
| Total Other Current Liabilities | 163.94% | 44.56% | -99.37% | -- | -- |
| Total Current Liabilities | -19.45% | -13.45% | -54.58% | -28.68% | -27.03% |
|
|
|||||
| Total Current Liabilities | -19.45% | -13.45% | -54.58% | -28.68% | -27.03% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -3.20% | -0.74% | -46.92% | -29.48% | -29.42% |
|
|
|||||
| Common Stock & APIC | 1.70% | 1.93% | 2.03% | 2.54% | 2.16% |
| Retained Earnings | -13.23% | -15.59% | -13.31% | -19.08% | -23.13% |
| Treasury Stock & Other | 78.26% | 87.15% | 112.12% | 81.95% | 78.37% |
| Total Common Equity | -41.93% | -41.83% | -32.43% | -36.20% | -37.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -41.93% | -41.83% | -32.43% | -36.20% | -37.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -41.93% | -41.83% | -32.43% | -36.20% | -37.71% |
|
|
|||||